Keywords: پالوییزوماب; bronchopulmonary dysplasia; palivizumab; preterm infant; respiratory syncytial virus; respiratory tract infection;
مقالات ISI پالوییزوماب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پالوییزوماب; bronchiolitis; hypertonic saline; palivizumab; respiratory syncytial virus;
Keywords: پالوییزوماب; palivizumab; premature infants; disease severity; hospitalizations; AAP; American Academy of Pediatrics; CHD; Congenital heart disease; CLD; Chronic lung disease; ICD-9; International Classification of Diseases, Ninth Revision; O2; Oxygen; PCR; Polymerase
Keywords: پالوییزوماب; Palivizumab; Prophylaxis; Respiratory syncytial virus; Lower respiratory tract infection; Latin America; Palivizumabe; Profilaxia; VÃrus sincicial respiratório; Infecção do trato respiratório inferior; América Latina;
Keywords: پالوییزوماب; Respiratory syncytial virus; lower respiratory tract infection; bronchiolitis; respiratory syncytial virus immunoprophylaxis; palivizumab; wheezing; asthma; primary prevention; AAP; American Academy of Pediatrics; CLD; Chronic lung disease; EGA; Estimated
Keywords: پالوییزوماب; Palivizumab; Guidelines; RSV; LRTI; Saudi; Prematurity
Keywords: پالوییزوماب; Respiratory syncytial virus; RSV; Virus-cell fusion; Palivizumab; Ribavirin; GS-5806;
Keywords: پالوییزوماب; Respiratory syncytial virus; Immunocompromised host; ECMO; Ribavirin; PalivizumabVirus respiratorio sincitial; Inmunodeprimido; ECMO; Ribavirina; Palivizumab
Keywords: پالوییزوماب; Respiratory syncytial virus; Bronchiolitis; Cystic fibrosis; Admission rate; Prophylaxis; Palivizumab;
Keywords: پالوییزوماب; Respiratory syncytial virus; Surveillance; HRSV; Palivizumab; Genotypes; Molecular; Epidemiology;
Keywords: پالوییزوماب; Respiratory Syncytial Virus, RSV; Viral coinfections; Bronchiolitis; Palivizumab; RNAi
Keywords: پالوییزوماب; Bronchiolitis; Infection control; Health care-associated infections; Infants; Palivizumab;
Oneâyear observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America
Keywords: پالوییزوماب; Palivizumab; Prophylaxis; Respiratory syncytial virus; Lower respiratory tract infection; Latin America; Palivizumabe; Profilaxia; VÃrus sincicial respiratório; Infecção do trato respiratório inferior; América Latina;
Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines
Keywords: پالوییزوماب; RSV; Vaccine; Neutralization; Antibody; Palivizumab; Live imaging. Ds-Cav1; F protein; Pre-fusion F; Animal model; Immune complex; Efficacy; Therapeutic; Treatment;
Infección por virus respiratorio sincitial en los pacientes inmunodeprimidos en un hospital pediátrico: experiencia de 5 años
Keywords: پالوییزوماب; Virus respiratorio sincitial; Inmunodeprimido; ECMO; Ribavirina; PalivizumabRespiratory syncytial virus; Immunocompromised Host; ECMO; Ribavirin; Palivizumab
Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome
Keywords: پالوییزوماب; Respiratory syncytial virus; Immunodeficiency; Down's syndrome; Additional indications; Palivizumab;
Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement
Keywords: پالوییزوماب; Respiratory syncytial virus; Lower respiratory tract disease; Palivizumab; Pulmonary function; Hematopoietic cell transplantation
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
Keywords: پالوییزوماب; Respiratory syncytial virus (RSV); Nanoparticle vaccine; Fusion protein (F protein); Microneutralization; Palivizumab; Competitive ELISA; Anti-F IgG; Aluminum phosphate; SF9 insect cell
Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction
Keywords: پالوییزوماب; Neonatal intensive care unit; Outbreak; Palivizumab; Polymerase chain reaction; Respiratory syncytial virus
CzÄstoÅÄ zakażeÅ ukÅadu oddechowego u dzieci z dysplazjÄ
oskrzelowo-pÅucnÄ
otrzymujÄ
cych profilaktycznie paliwizumab
Keywords: پالوییزوماب; noworodek przedwczeÅnie urodzony; BPD; paliwizumab; BPD; palivizumab; premature newborn;
Recomendaciones de uso de palivizumab para la prevención de la infección por virus respiratorio sincitial en prematuros de 321 a 350 semanas de gestación
Keywords: پالوییزوماب; VRS; Bronquiolitis; Hospitalización; Prematuros tardÃos; Anticuerpos monoclonales; Palivizumab; RSV; Bronchiolitis; Hospitalization; Late premature; Monoclonal antibodies; Palivizumab;
A Community Health Concern: Respiratory Syncytial Virus and Children
Keywords: پالوییزوماب; Children; Infants; Palivizumab; Prematurity; Respiratory syncytial virus (RSV); Respiratory tract infections
Preventing RSV bronchiolitis in vulnerable infants: The role of palivizumab
Keywords: پالوییزوماب; Respiratory syncytial virus [RSV]; Palivizumab; bronchiolitis; Infants; Chronic neonatal lung disease; Haemodynamically significant congenital heart disease
Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes
Keywords: پالوییزوماب; respiratory syncytial virus; neuromuscular diseases; immune deficiency syndromes; lower respiratory tract infection; palivizumab
Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
Keywords: پالوییزوماب; Human respiratory syncytial virus; Palivizumab; Resistance
ZapadalnoÅÄ na infekcje dróg oddechowych oraz czÄstoÅÄ hospitalizacji dzieci urodzonych przedwczeÅnie i poddanych profilaktyce zakażeÅ wirusem RS
Keywords: پالوییزوماب; zakażenie dróg oddechowych; wirus RS; wczeÅniactwo; dysplazja oskrzelowo-pÅucna (przewlekÅa choroba pÅucna); profilaktyka; palivizumab; respiratory tract infections; respiratory syncytial virus; prematurity; bronchopulmonary dysplasia (chronic lung
Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units
Keywords: پالوییزوماب; Respiratory syncytial virus; Outbreak; Palivizumab
Reducing the burden of respiratory syncytial virus: An audit of the use of palivizumab prophylaxis in the UK during the September 2001–March 2002 RSV season
Keywords: پالوییزوماب; Palivizumab; Audit; Respiratory syncytial virus; Disease burden; Implementation; Compliance
Aspects méthodologiques de l'évaluation économique du médicament en pédiatrie : exemple de la prophylaxie de l'infection à VRS en France
Keywords: پالوییزوماب; VRS; Asthme; Prophylaxie; Palivizumab; Prématurité; Cardiopathies congénitales;
Zastosowanie palivizumabu w leczeniu zakażenia dolnych dróg oddechowych wywoÅanego przez wirus RS u dziecka - opis przypadku
Keywords: پالوییزوماب; RSV; palivizumab; zapalenie dolnych dróg oddechowych; RSV; palivizumab; lower respiratory tract infection;
Impact of respiratory syncytial virus on hospital admissions in children younger than 3 years of age
Keywords: پالوییزوماب; Respiratory tract infection; Bronchiolitis; Pneumonia; Respiratory syncytial virus; Palivizumab; Mexico
Passive immunisation of preterm infants with palivizumab against RSV infection
Keywords: پالوییزوماب; Respiratory syncytial virus; Palivizumab; Monoclonal antibody; Systematic review; Cost effectiveness; Preterm infant
La eficiencia (coste-efectividad) de palivizumab como profilaxis para la infección por virus respiratorio sincitial en prematuros de 32-35 semanas en España
Keywords: پالوییزوماب; Infección por VRS; Prematuros; Coste-efectividad; Palivizumab; RSV infection; Premature infants; Cost-effectiveness; Palivizumab;
Management of infants with chronic lung disease of prematurity in Chile
Keywords: پالوییزوماب; Bronchopulmonary dysplasia; Chronic lung disease; Prematurity; Oxygen therapy; Home oxygen; RSV infection; Palivizumab; Steroids; Diuretics; Bronchodilators;